Alphamab Oncology Completes Share Placing by Controlling Shareholder

Alphamab Oncology ( (HK:9966) ) has provided an announcement.

Alphamab Oncology announced the completion of a share placing by its controlling shareholder, involving 14,600,000 shares, which represents approximately 1.51% of the company’s issued share capital. This transaction, executed at HK$8.05 per share, adjusts the shareholding distribution, with the Vendor now holding 31.0% of shares. This move is likely to impact the company’s market positioning and shareholder dynamics.

The most recent analyst rating on (HK:9966) stock is a Buy with a HK$7.00 price target. To see the full list of analyst forecasts on Alphamab Oncology stock, see the HK:9966 Stock Forecast page.

More about Alphamab Oncology

Alphamab Oncology is a biotechnology company focused on the research, development, and commercialization of innovative cancer therapies. The company operates within the pharmaceutical industry, primarily targeting oncology treatments to address unmet medical needs.

Average Trading Volume: 4,371,905

Technical Sentiment Signal: Hold

Current Market Cap: HK$8.04B

For an in-depth examination of 9966 stock, go to TipRanks’ Stock Analysis page.